Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperphagia × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10 Other hematologic neoplasm 2 Other 1 Genitourinary 1

Conditions

Obesity 333 Neoplasms 123 Breast Neoplasms 88 Mucositis 84 Overweight 81 Sexual Dysfunction, Physiological 77 Polycystic Ovary Syndrome 77 Dyspnea 52 Motor Activity 48 Weight Loss 33 Constipation 31 Prostatic Neoplasms 29 Head and Neck Neoplasms 28 Diabetes Mellitus 28 Colorectal Neoplasms 28 Endometrial Neoplasms 23 Depression 23 Lung Neoplasms 22 Diabetes Mellitus, Type 2 21 Multiple Endocrine Neoplasia Type 1 19 Cardiovascular Diseases 19 Anxiety Disorders 18 Pain 16 Obesity, Morbid 16 Metabolic Syndrome 16 Insulin Resistance 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Colonic Neoplasms 15 Cancer-related Fatigue 15 Stomatitis 14

Interventions

fish oil triglycerides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00533078 2015-07-23

LUNCH1

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed

Colitis, Hyperphagia, Infections, Neutropenia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡